Moreover, we hypothesise that increased proportions of type 1 to type 2 IFNs in this group of HIV-1 infected patients may further exacerbate their risk of active TB and contribute to the mechanisms of HIV immunodeficiency. Here, SGCG is linked to immunodeficiency disease.